With specialists focusing on virology, immunology and molecular biology, hLAB is well equipped within our Biosafety Level 2 and 3 facilities to provide high quality sample analysis and data outputs enabling clients to arrive at a proof of concept, or to make a breakthrough discovery in the pathology and possible treatment of diseases with unmet medical needs.
Our work includes assay development, transfer and optimisation across immunology, molecular and cell-based assays, including offering extensive options in sample matrix and stability testing and analysis. All assays are validated to FDA, EMA and ICH guidelines.
114,000+ lab assays and
samples in 2023
Bio-repository stores in
excess of 500,000 samples
Biosafety Level 3 (CAT 3) lab services available SARS-CoV-2-assays validated
Quality Standards GCLP, CAP Accredited and external QA, HTA, FLUCOP
In addition to our assay portfolio, hLAB has significant experience in sample -handling and -processing, routinely processing over 85,000 samples per year and managing over 500,000 samples in our biobank facility. We provide flexible options across a variety of sample processing methodologies, sample collection kit designs and assays to meet our client’s study design.
Reliable laboratory analysis underpinned by scientific expertise is essential when processing and analysing clinical samples. Robust quality processes support our team of scientists in the delivery of submission ready data.
